Christopher Parker
No más puestos en curso
Fortuna: 20 460 $ al 30/04/2024
Perfil
Christopher Parker served as the Managing Director for Roche Diagnostics Ltd.
from 2012 to 2017 and later as the Executive Director for AnteoTech Ltd.
from 2022 to 2023.
He received his undergraduate degree from Queensland University of Technology.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ANTEOTECH LTD
0.06% | 27/06/2023 | 1 500 000 ( 0.06% ) | 20 460 $ | 30/04/2024 |
Antiguos cargos conocidos de Christopher Parker.
| Empresas | Cargo | Fin |
|---|---|---|
| ANTEOTECH LIMITED | Director Ejecutivo | 01/12/2019 |
Roche Diagnostics Ltd.
 Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Roche Diagnostics Ltd. manufactures equipment and reagents for research and medical diagnostic applications. The company was founded on September 14, 1956 and is headquartered in Burgess Hill, the United Kingdom. | Corporate Officer/Principal | 01/07/2017 |
Formación de Christopher Parker.
| Queensland University of Technology | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ANTEOTECH LIMITED | Health Technology |
| Empresas privadas | 1 |
|---|---|
Roche Diagnostics Ltd.
Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Roche Diagnostics Ltd. manufactures equipment and reagents for research and medical diagnostic applications. The company was founded on September 14, 1956 and is headquartered in Burgess Hill, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Parker
